(BUSINESS WIRE)--OpGen, Inc., a commercial phase genomics and DNA analysis company, today announced that the Wellcome Trust Sanger Institute has purchased an Argus™ Optical Mapping System in order to reduce the time and cost of whole genome sequence assembly.
